- Research works
- 23 ▲ 55% vs 2013–17
- Citations
- 494 21.8 per fractional work
- Top-10% rate
- 17.5% record average 16.5%
- Open access
- 70% world 28%
Not ranked overall: Visterra (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 9.7×. Every wedge is a field page.
Which keywords describe research at Visterra (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Epidemiology, Glomerular Diseases and Nephrotic Syndrome.
- Influenza
- Antibodies
- Virus
- Genomics
- Nephrotic Syndrome
- Fc Receptors
- Therapeutic Antibodies
- Glycosylation
- Epidemiology
- Monoclonal Antibodies
- Antibody Engineering
- Glomerular Diseases
- Pathogenesis
- TGF-ß
- Autoimmunity
- H1N1
- Rituximab
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 17 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 17 words, with their numbers
- Epidemiology3▲ 3.5×10 topics
- Glycosylation3▲ 58×3 topics
- Monoclonal Antibodies3▲ 85×2 topics
- Therapeutic Antibodies3▲ 95×2 topics
- Antibody Engineering2▲ 98×1 topic
- Fc Receptors2▲ 98×1 topic
- Glomerular Diseases2▲ 265×1 topic
- Nephrotic Syndrome2▲ 265×1 topic
- Pathogenesis1▲ 11×4 topics
- Genomics1▲ 16×2 topics
- TGF-ß1▲ 34×2 topics
- Virus1▲ 47×2 topics
- Autoimmunity1▲ 26×2 topics
- Antibodies1▲ 57×2 topics
- H1N11▲ 133×1 topic
- Influenza1▲ 100×1 topic
- Rituximab1▲ 30×3 topics
Which research topics does Visterra (United States) publish most on?
By volume in 2022–2025: Renal Diseases and Glomerulopathies, Platelet Disorders and Treatments, Immunodeficiency and Autoimmune Disorders and Autoimmune Bullous Skin Diseases.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Renal Diseases and Glomerulopathies Nephrology 2 works
- 2 Platelet Disorders and Treatments Hematology 0 works
- 3 Immunodeficiency and Autoimmune Disorders Immunology 0 works
- 4 Autoimmune Bullous Skin Diseases Pathology and Forensic Medicine 0 works
- 5 Chronic Kidney Disease and Diabetes Nephrology 0 works
- 6 Identification and Quantification in Food Molecular Biology 0 works
- 7 Renal and related cancers Molecular Biology 0 works
- 8 Cancer Genomics and Diagnostics Cancer Research 0 works
- 9 Protein Hydrolysis and Bioactive Peptides Molecular Biology 0 works
- 10 Single-cell and spatial transcriptomics Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Visterra (United States)'s research output changed?
Output in 2018–2022 was 55% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Cambridge
- Harvard University
- Massachusetts Institute of Technology
- Center for Astrophysics Harvard & Smithsonian
- National Bureau of Economic Research
- IIT@MIT
- World Wide Web Consortium
- Broad Institute
- Smithsonian Astrophysical Observatory
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.